AstraZeneca Income from Continuous Operations 2010-2024 | AZN
AstraZeneca income from continuous operations for the twelve months ending September 30, 2024 was $6.500B, a 10.08% increase year-over-year.
- AstraZeneca annual income from continuous operations for 2023 was $5.961B, a 81.02% increase from 2022.
- AstraZeneca annual income from continuous operations for 2022 was $3.293B, a 2763.48% increase from 2021.
- AstraZeneca annual income from continuous operations for 2021 was $0.115B, a 96.34% decline from 2020.